Huang, Shenjia
Bian, Yicong
Huang, Chenrong
Miao, Liyan
Funding for this research was provided by:
National Natural Science Foundation of China (81773820)
Article History
Accepted: 27 June 2022
First Online: 1 August 2022
Declarations
:
: This work was supported by the National Natural Science Foundation of China (81773820), the National Key New Drug Creation Special Programs (2017ZX09304-021), Suzhou Talent Research Project (GSWS2019036), and Hospital Pharmacy Committee of Chinese Pharmaceutical Association (CPA-Z05-ZC-2021-002).
: The authors declare no conflict of interest.
: All data are included in the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Chenrong Huang and Shenjia Huang had the idea for the article. Shenjia Huang and Yicong Bian performed the literature search, and drafted and wrote the manuscript. Chenrong Huang and Liyan Miao critically revised the manuscript.